Immunobead multiplex RT-PCR detection of carcinoembryonic genes expressing cells in the blood of colorectal cancer patients

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 2, 2005, Pages 127-132

  Douard, Richard ^a,b   Moutereau, Stéphane ^b   Serru, Valérie ^c   Sales, Jean Patrick ^c   Wind, Philippe ^d   Cugnenc, Paul Henri ^a   Vaubourdolle, Michel ^c   Loric, Sylvain ^b  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d AVICENNE HOSPITAL   (France)

Author keywords

Carcinoembryonic antigen related cell adhesion molecule 5 (CEACAM5); Carcinoembryonic antigen related cell adhesion molecule 7 (CEACAM7); Circulating cells; Colorectal cancer; Immunobead; Multiplex reverse transcriptase polymerase chain reaction (RT PCR)

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 5; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 7; COMPLEMENTARY DNA; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD CELL; BLOOD SAMPLING; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE CELL; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SENSITIVITY ANALYSIS;

AGED; BASE SEQUENCE; CARCINOEMBRYONIC ANTIGEN; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 14944360606     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2005.021     Document Type: Article

References (24)

1. Jonas S, Windeatt S, O-Boateng A, Fordy C, Allen-Mersh TG. Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction. Gut 1996;39:717-21.
2. Douard R, Le Maire V, Wind P, Sales JP, Dumas F, Fayemendi L, et al. Carcinoembryonic gene member 2 mRNA expression as a marker to detect circulating enterocytes in the blood of colorectal cancer patients. Surgery 2001;129:587-94.
3. Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, et al. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. Cancer Res 2001;61:2523-32.
4. Goeminne JC, Guillaume T, Salmon M, Machiels JP, D'Hondt V, Symann M. Unreliability of carcinoembryonic antigen (CEA) reverse transcriptase-polymerase chain reaction (RT-PCR) in detecting contaminating breast cancer cells in peripheral blood stem cells due to induction of CEA by growth factors. Bone Marrow Transplant 1999;24:769-75.
5. Park S, Lee B, Kim I, Choi I, Hong K, Ryu Y, et al. Immunobead RT-PCR versus regular RT-PCR amplification of CEA mRNA in peripheral blood. J Cancer Res Clin Oncol 2001;127:489-94.
6. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
7. Matsumura M, Niwa Y, Kato N, Komatsu Y, Shiina S, Kawabe T, et al. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology 1994;20:1418-25.
8. Jung R, Kruger W, Hosch S, Holweg M, Kroger N, Gutensohn K, et al. Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro. Br J Cancer 1998;78:1194-8.
9. Nollau P, Prall F, Helmchen U, Wagener C, Neumaier M. Dysregulation of carcinoembryonic antigen group members CGM2, CD66a (biliary glycoprotein), and nonspecific cross-reacting antigen in colorectal carcinomas, Comparative analysis by northern blot and in situ hybridization. Am J Pathol 1997;151:521-30.
10. Kinugasa T, Kuroki M, Takeo H, Matsuo Y, Ohshima K, Yamashita Y, et al. Expression of four CEA family antigens (CEA, NCA, BGP and CGM2) in normal and cancerous gastric epithelial cells: up-regulation of BGP and CGM2 in carcinomas. Int J Cancer 1998;76:148-53.
11. Walker J, Quirke P. Prognosis and response to therapy in colorectal cancer. Eur J Cancer 2002;38:880-6.
12. Marchena J, Acosta MA, Garcia-Anguiano F, Simpson H, Cruz F. Use of the preoperative levels of CEA in patients with colorectal cancer. Hepatogastroenterology 2003; 52:1017-20.
13. Frangsmyr L, Israelsson A, Teglund S, Matsunaga T, Hammarstrom S. Evolution of the carcinoembryonic antigen family structures of CGM9, CGM11 and pregnancy-specific glycoprotein promoters. Tumour Biol 2000;21:63-81.
14. Daniel S, Nagel G, Johnson JP, Lobo FM, Hirn M, Jantscheff P, et al. Determination of the specificities of monoclonal antibodies recognizing members of the CEA family using a panel of transfectants. Int J Cancer 1993;55:303-10.
15. Thompson J, Zimmermann W, Nollau P, Neumaier M, Weber-Arden J, Schrewe H, et al. CGM2, a member of the carcinoembryonic antigen gene family is down-regulated in colorectal carcinomas. J Biol Chem 1994;269:32924-31.
16. Scholzel S, Zimmermann W, Schwarzkopf G, Grunert F, Rogaczewski B, Thompson J. Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas. Am J Pathol 2000;156:595-605.
17. Fahlgren A, Baranov V, Frângsmyr L, Zoubir F, Hammarstrom ML, Hammarstrom S. Interferon-γ tempers the expression of carcinoembryonic antigen family molecules in human colon cells: a possible role in innate mucosal defence. Scand J Immunol 2003;58:628-41.
18. Thompson J, Mossinger S, Reichardt V, Engels U, Beauchemin N, Kommoss F, et al. A polymerase-chain-reaction assay for the specific identification of transcripts encoded by individual carcinoembryonic antigen (CEA)-gene-family members, Int J Cancer 1993;55:311-9.
19. Wharton RQ, Patel H, Jonas SK, Glover C, Weston M, Allen-Mersh TG. Venesection needle coring increases positive results with RT-PCR for detection of circulating cells expressing CEA mRNA. Clin Exp Metastasis 2000;18:291-4.
20. Piva MG, Navaglia F, Basso D, Fogar P, Roveroni G, Gallo N, et al. CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging. Oncology 2000;59:323-8.
21. Al-Mulla F, Keith WN, Pickford IR, Going JJ, Birnie GD. Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases. Genes Chromosomes Cancer 1999;24:306-14.
22. Giovagnoli MR, Giarnieri E, Midiri G, Tesoriere A, Ferraro S, Vecchione A. Intratumoral heterogeneity in colorectal carcinoma: trucut sampling for DNA ploidy analysis. Anticancer Res 1999;19:4577-80.
23. Baisse B, Bouzourene H, Saraga EP, Bosman FT, Benhattar J. Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma. Int J Cancer 2001;93:346-52.
24. Oberg AN, Lindmark GE, Israelsson AC, Hammarstrom SG, Hammarstrom ML. Detection of occult tumour cells in lymph nodes of colorectal cancer patients using quantitative RT-PCR for CEA and CK20 mRNAs. Int J Cancer 2004;111:101-10.